2.6691
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AVXL?
Forum
Prognose
Aktiensplit
Anavex Life Sciences Corp Aktie (AVXL) Neueste Nachrichten
Anavex Life Sciences (AVXL) Faces Nasdaq Compliance Challenge - GuruFocus
Anavex (AVXL) Faces Nasdaq Notification Due to Filing Delay - GuruFocus
Anavex Life Sciences receives Nasdaq delisting warning - Investing.com UK
Anavex Life Sciences receives Nasdaq delisting warning By Investing.com - Investing.com South Africa
symbol__ Stock Quote Price and Forecast - CNN
Anavex Life Sciences receives expected Nasdaq delinquency notification - marketscreener.com
Anavex Life Sciences Received Notice of Noncompliance - TradingView
Nasdaq warns Anavex (Nasdaq: AVXL) over delayed quarterly filing - Stock Titan
Anavex Life Sciences Corp. Receives Delinquency Notification from Nasdaq for Non-Compliance with Listing Rule - Quiver Quantitative
Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification - Anavex Life Sciences
Nasdaq flags Anavex for missing 10-Q, gives July 20 fix date - Stock Titan
AVXL Stock Price, Quote & Chart | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill
Anavex Life Sciences stock crushed as European Alzheimer's drug filing pulled after EMA pushback - MSN
Anavex Life Sciences Announces COO Departure Amid Restructuring - The Globe and Mail
Anavex (AVXL) COO exits amid reorganization; option grant largely forfeited - Stock Titan
Anavex (AVXL) interim CEO discloses detailed stock option grants - Stock Titan
Anavex withdraws EU approval filing for Alzheimer’s therapy - MSN
Anavex Stock Just Logged Its Worst Selloff In 2 Years — What Does EMA’s Oral Explanation Week Mean For Its Alzheimer’s Drug? - MSN
AVXL stock tanks after Anavex withdraws EU bid for Alzheimer's drug - MSN
Anavex Delays Quarterly Filing Amid CEO Shake-Up - The Globe and Mail
TradingKey - TradingKey
Anavex Life Sciences (AVXL) Delays Quarterly Report Submission - GuruFocus
AVXL SEC FilingsAnavex Life Scie 10-K, 10-Q, 8-K Forms - Stock Titan
Anavex Life Sciences (NASDAQ: AVXL) delays 10-Q after CEO termination - Stock Titan
MSN Money - MSN
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring A 605% Upside Potential - DirectorsTalk Interviews
Biopharma veteran takes her CEO Cue—Chutes & Ladders - Fierce Biotech
Anavex (AVXL) Appoints Interim CEO Amid Leadership Change - GuruFocus
Anavex Life Sciences Names Interim CEO Amid Leadership Shift - The Globe and Mail
Number of shareholders of Anavex Life Sciences Corp. – FWB:12X1 - TradingView
Anavex Life Sciences Appoints Terrie Kellmeyer as Interim CEO Following Christopher Missling’s Departure - Minichart
Anavex appoints interim CEO following leadership change - Investing.com UK
CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus - Yahoo Finance
Anavex stock slips after CEO transition (AVXL:NASDAQ) - Seeking Alpha
Anavex appoints interim CEO following leadership change By Investing.com - Investing.com India
CEO ousted as Anavex (NASDAQ: AVXL) board installs interim chief and eyes 10-Q delay - Stock Titan
Anavex Life Sciences (AVXL) to Release Earnings on Tuesday - MarketBeat
H.C. Wainwright initiates Anavex Life Sciences stock with buy rating - Investing.com UK
H.C. Wainwright initiates Anavex Life Sciences stock with buy rating By Investing.com - Investing.com South Africa
Director Axel Paeger files initial Form 3 for Anavex (AVXL) - Stock Titan
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):